Extended-Release Naltrexone for Alcohol and Opioid Problems in Missouri Parolees and Probationers

Journal of Substance Abuse Treatment

Volumn 56, Issue , 2015, Pages 54-60

  Crits Christoph, Paul ^a   Lundy, Christie ^b   Stringer, Mark ^b   Gallop, Robert ^c   Gastfriend, David R ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^c WEST CHESTER UNIVERSITY   (United States)

^d TREATMENT RESEARCH INSTITUTE   (United States)

Author keywords

Alcohol; Extended release naltrexone; Medication assisted therapy; Opioids; Substance abuse

Indexed keywords

ALCOHOL; BUPRENORPHINE PLUS NALOXONE; CANNABIS; EXTENDED RELEASE NALTREXONE; NALTREXONE; OPIATE; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; NARCOTIC ANTAGONIST;

ABSTINENCE; ADULT; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RETROSPECTIVE STUDY; SELF HELP; TREATMENT DURATION; TREATMENT OUTCOME; ALCOHOL-RELATED DISORDERS; DELAYED RELEASE FORMULATION; MIDDLE AGED; MISSOURI; OFFENDER; OPIOID-RELATED DISORDERS; OUTCOME ASSESSMENT; STATISTICS AND NUMERICAL DATA;

ADULT; ALCOHOL-RELATED DISORDERS; CRIMINALS; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MISSOURI; NALTREXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84937725453     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2015.03.003     Document Type: Article

References (35)

1. Adamson S.J., Sellman J.D. The pattern of intravenous drug use and associated criminal activity in patients on a methadone treatment waiting list. Drug and Alcohol Review 1998, 17(2):159-166. 10.1080/09595239800186961.
2. Austin P.C. Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score. Pharmacoepidemiology and Drug Safety 2008, 17:1202-1217. 10.1002/pds.1673.
3. Austin P.C., Mamdani M.M. A comparison of propensity score methods: A case-study estimating the effectiveness of post-AMI statin use. Statistics in Medicine 2006, 25:2084-2106. 10.1002/sim.2328.
4. Bennett T., Holloway K. The causal connection between drug misuse and crime. British Journal of Criminology 2009, 49(4):513-531. 10.1093/bjc/azp014.
5. Coviello D.M., Cornish J.W., Lynch K.G., Boney T.Y., Clark C.A., Lee J.D., et al. A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers. Substance Abuse 2012, 33(1):48-59. 10.1080/08897077.2011.609438.
6. Dolan K.A., Shearer J., White B., Zhou J., Kaldor J., Wodak A.D. Four-year follow-up of imprisoned male heroin users and methadone treatment: Mortality, re-incarceration and hepatitis C infection. Addiction 2005, 100(6):820-828. 10.1111/j.1360-0443.2005.01050.x.
7. Faries D., Leon A.C., Haro J.M., Obenchain R.L. Analysis of observational health care data using SAS 2010, Sas Institute Inc., Cary, NC.
8. Finigan M.W., Perkins T., Zold-Kilbourn P., Parks J., Stringer M. Preliminary evaluation of extended-release naltrexone in Michigan and Missouri drug courts. Journal of Substance Abuse Treatment 2011, 41(3):288-293. 10.1016/j.jsat.2011.04.003.
9. Garcia C.A., Correa G.C., Viver A.D.H., Kinlock T.W., Gordon M.S., Avila C.A., et al. Buprenorphine-naloxone treatment for pre-release opioid-dependent inmates in Puerto Rico. Journal of Addiction Medicine 2007, 1(3):126-132. 10.1097/ADM.0b013e31814b8880.
10. Gastfriend D.R. Intramuscular extended-release naltrexone: Current evidence. Annals of the New York Academy of Sciences 2011, 1216(1):144-166. 10.1111/j.1749-6632.2010.05900.x.
11. Gordon M.S., Kinlock T.W., Schwartz R.P., Fitzgerald T., O'Grady K.E., Vocci F.J. A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry. Drug and Alcohol Dependence 2014, 142(1):33-40. 10.1016/j.drugalcdep.2014.05.011.
12. Hedrich D., Alves P., Farrell M., Stöver H., Møller L., Mayet S. The effectiveness of opioid maintenance treatment in prison settings: A systematic review. Addiction 2012, 107(3):501-517. 10.1111/j.1360-0443.2011.03676.x.
13. Hong G., Raudenbush S.W. Evaluating kindergarten retention policy: A case study of causal inference for multilevel observational data. Journal of the American Statistical Association 2006, 101:901-910. 10.1198/016214506000000447.
14. Karberg J.C., James D.J. Substance dependence, abuse, and treatment of jail inmates, 2002. Dept of Justice publication NCJ209588 2005, Office of Justice Programs, Bureau of Justice Statistics, Washington, DC.
15. Keene J. A case-linkage study of the relationship between drug misuse, crime, and psychosocial problems in a total criminal justice population. Addiction Research & Theory 2005, 13(5):489-502. 10.1080/16066350500166588.
16. Kinlock T.W., Gordon M.S., Schwartz R.P. Incarcerated populations. Lowinson & Ruiz's substance abuse: A comprehensive textbook 2011, 5. Lippincott Williams & Wilkins. P. Ruiz, E. Strain (Eds.).
17. La Vigne N.G., Visher C., Castro J. Chicago prisoners' experiences returning home. The urban institute 2004, (Accessed from: http://www.urban.org/UploadedPDF).
18. Lapham S.C., McMillan G.P. Open-label pilot study of extended-release naltrexone to reduce drinking and driving among repeat offenders. Journal of Addiction Medicine 2011, 5(3):163-169. 10.1097/ADM.0b013e3181eb3b89.
19. Lobmaier P.P., Kunøe N., Waal H. Treatment research in prison: Problems and solutions in a randomized trial. Addiction Research & Theory 2010, 18(1):1-13. 10.3109/16066350802531273.
20. Martin S.S., Butzin C.A., Saum C.A., Inciardi J.A. Three-year outcomes of therapeutic community treatment for drug-involved offenders in Delaware: From prison to work release to aftercare. The Prison Journal 1999, 79(3):294-320.
21. Maruschak L.M., Bonczar T.P. Bureau of Justice Statistics, U.S. Dept of Justice, & Office of Justice Programs. Probation and parole in the United States, 2012 2013, (Retrieved from: http://www.bjs.gov/content/pub/pdf/ppus12.pdf).
22. Matusow H., Dickman S.L., Rich J.D., Fong C., Dumont D.M., Hardin C., et al. Medication assisted treatment in U.S. drug courts: Results from a nationwide survey of availability, barriers and attitudes. Journal of Substance Abuse Treatment 2013, 44(5):473-480. 10.1016/j.jsat.2012.10.004.
23. Minozzi S., Amato L., Vecchi S., Davoli M., Kirchmayer U., Verster A. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database of Systematic Reviews 2006, 1. 10.1002/14651858.CD001333.pub2.
24. Mumola C.J., Karberg J.C. Drug use and dependence, state and federal prisoners, 2004 2006, U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics, Washington, DC.
25. National Institute of Justice Arrestee drug abuse monitoring: Annual report 2003, National Institute of Justice, Washington, DC.
26. National Institute on Drug Abuse Principles of drug addiction treatment: A research-based guide 1999, Author, Bethesda, MD.
27. National Institute on Drug Abuse Principles of drug abuse treatment for criminal justice populations: A research-based guide 2006, Author, Bethesda, MD.
28. Nochajski T.H., Stasiewicz P.C. Relapse to driving under the influence (DUI): A review. Clinical Psychology Review 2006, 26:179-195. 10.1016/j.cpr.2005.11.006.
29. O'Brien C.P., Friedmann P.D., Nunes E., Lee J.D., Kinlock T.W. Depot naltrexone as relapse prevention for opioid--dependent parolees. Poster session presented at the meeting of The College on Problems of Drug Dependence Annual Scientific Meeting. San Juan, Puerto Rico 2014.
30. SAS Institute Inc SAS/STAT 9.3 user's guide 2011, SAS Institute Inc., Cary, NC.
31. Smith R.C., Lundy C.J., Rothermich R.M. Status report on Missouri's substance abuse and mental health problems, nineteenth edition - 2013 Retrieved at:. http://dmh.mo.gov/docs/ada/rpts/Status2013/a02.pdf.
32. Spreeuwenberg M.D., Bartak A., Croon M.A., Hagenaars J.A., Busschbach J.J., Andrea H., et al. The multiple propensity score as control for bias in the comparison of more than two treatment arms: An introduction from a case study in mental health. Medical Care 2010, 48:166-174.
33. Substance Abuse and Mental Health Services Administration Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-46, HHS Publication No. (SMA) 13-4795 2013, Substance Abuse and Mental Health Services Administration, Rockville, MD, Retrieved from: http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm.
34. Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality. The NSDUH report: Trends in substance use disorders among males aged 18 to 49 on probation or parole 2014, (Rockville, MD).
35. Taxman F.S., Perdoni M.L., Harrison L.D. Drug treatment services for adult offenders: The state of the state. Journal of Substance Abuse Treatment 2007, 32(3):239-254. 10.1016/j.jsat.2006.12.019.